Unfortunately, multi-drug resistant tuberculosis (MDR-TB), which is any TB resistant to the traditional treatments of isoniazid and rifampicin, represents a serious challenge: because standard treatment is less effective in curing it, its transmission continues.
Desafortunadamente, la tuberculosis resistente a múltiples drogas (MDR-TB), que es cualquier tuberculosis resistente a los tratamientos tradicionales de isoniazida y rifampicina, representa un desafío importante: dado que el tratamiento estándar es menos efectivo para curarla, su transmisión continúa.